Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3880950010 | Product containing only crizanlizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3880951014 | Crizanlizumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2847251000001115 | Crizanlizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2847261000001117 | Crizanlizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Crizanlizumab | Is a | Product containing crizanlizumab (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Crizanlizumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Crizanlizumab | Has active ingredient | Crizanlizumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Crizanlizumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only crizanlizumab in parenteral dose form (medicinal product form) | Is a | True | Crizanlizumab | Inferred relationship | Existential restriction modifier | |
| Crizanlizumab 100mg/10ml solution for infusion vials | Is a | True | Crizanlizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR